If you are interested in investing in the experimental psychedelics industry, look closely at what companies are doing in this sector, as well as how stocks historically perform. Psychedelic stocks are prone to volatile conditions — in both the markets and in the experimental drugs industry, so thoroughly research the stocks before investing. With that in mind, here are the top three psychedelic stocks that are moving the needle in the industry. While it is still early days in the industry, the promising potential of the pharmaceuticals of the psychedelic drug space has attracted a keen investor — and this is because these psychedelic stocks present a nascent investment opportunity.
Given the potential for growth of this industry, Wall Street analysts are expecting the top performers to come from the psychedelic stocks Mind Medicine (MindMed) Inc. (MNMD), Cybin Inc. (CYBN), and Field Trip Health Ltd. (FTRP). Among the handful of publicly traded psychedelic companies that are also conducting clinical trials and have attracted interest from investors is Mind Medicine (MindMed) Inc. (MMED) (MMEDF), a neuroscience-based pharmaceutical company discovering, developing, and commercializing psychedelic-inspired medicines for improving health, promoting well-being, and relieving pain. I would rate MindMed shares as hold because of the higher risk that investors could lose all their investments to a different company, should the DEA and FDA refuse to change the classification, but i–and, even more important, a sizable segment of the scientific community–believe there may be a truly effective treatment somewhere within the mix of psychedelic medicine. We have said before, and we will say it again, that the real money in psychedelics is going to come from the FDA approved drugs to treat depression and mental health.
Some stocks worth considering, says Sylvia Jablonski, include Mind Medicine, which is focused on LSD, and the psychedelic drug ibogaine, which targets depression, anxiety, attention deficit disorder, and addiction.